Butterfly Network, Inc.

We created the world’s first handheld, whole-body ultrasound probe: the Butterfly iQ. This innovative device reduces the cost of the traditional ultrasound system by miniaturizing it onto a single semiconductor silicon chip with our patented Ultrasound-on-Chip™ technology.

We’ve paired our handheld probe with cloud-based software to create a true imaging solution—one that delivers vital information, in a variety of use cases, across multiple care settings. This information supports timely clinical decision-making and creates workflow improvements that help clinicians achieve better outcomes for the people in their care.

Our Butterfly iQ and next-generation Butterfly iQ+ have received CE Mark and FDA clearance, and are being sold in hospitals and clinics in 20 countries around the world. In 2021, Butterfly began trading publicly on the NYSE.
By joining Butterfly Network, you will be helping to transform the future of healthcare. Our team helps us maximize global impact, motivated by the idea that our products will impact the lives of millions, including the people they love.